During the past decade, Pablo Roman conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pablo Roman" are "Fibromyalgia" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Pablo Roman" in a lesser frequency.

Most popular intervention types in "Pablo Roman" are "Dietary Supplement" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Lactobacillus Rhamnosus GG ®" (1 trials), "Lactobacillus acidophilus" (1 trials) and "Lactobacillus rhamnosus and Bifidobacterium lactis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pablo Roman" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Pablo Roman". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pablo Roman, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pablo Roman, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".